The overall aims of the eurILDreg, in collaboration with the RARE-ILD consortium, are to
- describe the natural course of different forms of ILDs
- analyse differences in genetically defined forms of ILD between childhood and
adulthood
- develop novel, primarily non-invasive, diagnostic, prognostic and therapeutic
biomarkers,
- provide new algorithms for diagnostic workup, longitudinal follow-up and
treatment
- analyse quality of life in the different ILD cohorts
- study the impact of environmental factors on disease initiation and progression
- establish the role of exacerbations in the initiation and progression of ILDs
- create a most comprehensive, coherent and conclusive set of big data in the
field of ILD, including deep phenome, imaginome, epi/genome, proteome,
transcriptome, and the volatolome.
- analyse this big data set employing artificial intelligence and computational
modeling.
